Association between ACYP2 polymorphisms and the risk of renal cell cancer

ConclusionIn summary, the results suggested thatACYP2 polymorphisms could be used as a genetic marker for RCC. Additional functional and association studies are required to validate our results.

Source: Molecular Genetics & Genomic Medicine - September 4, 2019 Category: Genetics & Stem Cells Authors: Yuhe Wang, Yongtong Zhang, Yao Sun, Jiamin Wu, Junke Chang, Zichao Xiong, Fanglin Niu, Shanzhi Gu, Tianbo Jin Tags: ORIGINAL ARTICLE Source Type: research